Over 12 years experience in biomarker discovery
SKULDTECH AT A GLANCE
Skuldtech is specialized in the discovery of
Biomarkers and the development of Diagnostics
focused on personalized medicine applications.
This expertise enables the company to provide
genomic, pharmacogenomic and transcriptomic services,
as well as innovative diagnostics
associated with new
therapeutics especially in
cancer, rare diseases and
infectious diseases.
LATEST NEWS AND PRESS REVIEW
- 2012: "Skuldtech, partner of a bioinformatic center in Montpellier"
- BJH 2012: "New prognostic markers reveal two distinct subtypes of CMML patients"
- DTA 2012: The Skuldtech scientific team studies on EPO transcriptomic biomarkers remarked by the...
Skuldtech will attend the Euromediag International Convention 2012 (Montpellier-France, July 5-6, 2012)




